Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 21
2013 22
2014 26
2015 26
2016 51
2017 40
2018 36
2019 32
2020 24
2021 21
2022 21
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

293 results
Results by year
Filters applied: . Clear all
Page 1
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
Greig SL, Deeks ED. Greig SL, et al. Drugs. 2016 Jun;76(9):957-68. doi: 10.1007/s40265-016-0586-z. Drugs. 2016. PMID: 27189707 Review.
Tenofovir AF has been coformulated with elvitegravir, cobicistat and emtricitabine as a once-daily, single-tablet regimen (elvitegravir/cobicistat/emtricitabine/tenofovir AF; Genvoya()) for the treatment of adults and adoles
Tenofovir AF has been coformulated with elvitegravir, cobicistat and emtricitabine as a once-daily, single-table
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.
Bonora S, Calcagno A, Trentalange A, Di Perri G. Bonora S, et al. Expert Opin Pharmacother. 2016;17(3):409-19. doi: 10.1517/14656566.2016.1129401. Expert Opin Pharmacother. 2016. PMID: 26642079 Review.
INTRODUCTION: Tenofovir alafenamide (TAF) is is a novel tenofovir prodrug with a 90% reduction in plasma tenofovir concentrations as compared to tenofovir disoproxil fumarate (TDF) and such property suggests that TAF-containing regimens can improve ren …
INTRODUCTION: Tenofovir alafenamide (TAF) is is a novel tenofovir prodrug with a 90% reduction in plasma tenofovir conc …
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults.
Perry CM. Perry CM. Drugs. 2014 Jan;74(1):75-97. doi: 10.1007/s40265-013-0158-4. Drugs. 2014. PMID: 24338165 Review.
A new single-tablet, fixed-dose formulation consisting of elvitegravir, an HIV-1 integrase strand transfer inhibitor (INSTI); cobicistat, a pharmacokinetic enhancer; emtricitabine, a nucleoside reverse transcriptase inhibitor; and tenofovir disoproxil …
A new single-tablet, fixed-dose formulation consisting of elvitegravir, an HIV-1 integrase strand transfer inhibitor (INSTI); cobi
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (EVG/COBI/FTC/TAF) (Genvoya) Fixed-Dose Combination, Oral Tablet) [Internet].
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov. PMID: 28121099 Free Books & Documents. Review.
The objective of this systematic review is to evaluate of the beneficial and harmful effects of the fixed-dose combination (FDC) of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/COBI/FTC/TAF) for the treatment of human immunodeficien …
The objective of this systematic review is to evaluate of the beneficial and harmful effects of the fixed-dose combination (FDC) of elvit
Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide -- Addendum to Commission A15-61 [Internet].
Institute for Quality and Efficiency in Health Care. Institute for Quality and Efficiency in Health Care. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 May 27. Extract of Dossier Assessment No. A16-27. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 May 27. Extract of Dossier Assessment No. A16-27. PMID: 29144710 Free Books & Documents. Review.
Background On 9 May 2016, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to conduct supplementary assessments for Commission A15-61 (Elvitegravir / Cobicistat / Emtricitabine / Tenofovir
Background On 9 May 2016, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to …
Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatment.
Manzardo C, Gatell JM. Manzardo C, et al. AIDS Rev. 2014 Jan-Mar;16(1):35-42. AIDS Rev. 2014. PMID: 24584107 Review.
Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) is a new single-tablet, fixed-dose formulation approved by both the US Food and Drug Administration and the European Medicine Agency as antiretroviral therapy. ...Stribild h …
Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) is a new single-tablet, fixed-dos …
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment.
Olin JL, Spooner LM, Klibanov OM. Olin JL, et al. Ann Pharmacother. 2012 Dec;46(12):1671-7. doi: 10.1345/aph.1R468. Epub 2012 Nov 7. Ann Pharmacother. 2012. PMID: 23136357 Review.
OBJECTIVE: To review the clinical trials, pharmacologic characteristics, safety, and efficacy of the elvitegravir/cobicistat/emtricitabine/tenofovir single tablet formulation (Stribild). DATA SOURCES: Literature searches were performed in MEDLINE (1948 …
OBJECTIVE: To review the clinical trials, pharmacologic characteristics, safety, and efficacy of the elvitegravir/cobicistat/ …
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide discontinuation and return to normal weight.
Max B, DeMarais P. Max B, et al. Int J STD AIDS. 2021 Jan;32(1):92-95. doi: 10.1177/0956462420964341. Epub 2020 Nov 11. Int J STD AIDS. 2021. PMID: 33176608
However, emerging data from clinical trials has identified excessive weight gain possibly due to INSTI alone or with tenofovir alafenamide as a new and possible long-term complication of combination antiretroviral therapy (cART). ...We report a return to baseline weight af …
However, emerging data from clinical trials has identified excessive weight gain possibly due to INSTI alone or with tenofovir alafen …
Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide -- Benefit Assessment According to §35a Social Code Book V [Internet].
Institute for Quality and Efficiency in Health Care. Institute for Quality and Efficiency in Health Care. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Mar 30. Extract of Dossier Assessment No. A15-61. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Mar 30. Extract of Dossier Assessment No. A15-61. PMID: 29144685 Free Books & Documents. Review.
Background In accordance with 35a Social Code Book (SGB) V, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to assess the benefit of the drug combination elvitegravir / cobicistat / emtricitabine
Background In accordance with 35a Social Code Book (SGB) V, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Ef …
293 results